ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Lewis Base Catalyzed Synthesis of
Multisubstituted 4‑Sulfonyl‑1H‑Pyrazole
Involving a Novel 1,3-Sulfonyl Shift
Yu Zhu, Wen-Ting Lu, Hong-Chao Sun, and Zhuang-Ping Zhan*
Department of Chemistry, College of Chemistry and Chemical Engineering,
Xiamen University, Xiamen 361005, Fujian, P. R. China
Received June 28, 2013
ABSTRACT
A facile synthesis of highly substituted 4-sulfonyl-1H-pyrazoles from N-propargylic sulfonylhydrazone derivatives has been developed. Allenic
sulfonamide formation and 1,3-sulfonyl shift were established to be the critical steps of this transformation.
Pyrazoles and their derivatives have been recognized as
important frameworks in pharmaceutical and agrochem-
ical science,1 and certain pyrazole derivatives including
Celebrex (selective COX-2 inhibition) and Zoniporide
(selective human NHE-1 inhibition) have been developed
into clinical drugs. Owing to the attractive medicinal
properties of pyrazoles, new approaches for the efficient
assembly of different pyrazoles have attracted great inter-
est. Efficient strategies have beendevelopedwiththe aim of
the preparation of diverse substitution pyrazoles.2 Con-
ventional approaches for the synthesis of compounds
containing pyrazole skeletons involve either the modifica-
tion of the pre-existing pyrazole precursors through the
introduction of new groups3 or synthesis of a new pyrazole
ring from creation of CÀN and CÀC bonds.4
(1) (a) Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.;
Collins, P. W.; Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.;
Miyashiro, J. M. J. Med. Chem. 1997, 40, 1347. (b) Guzman-Perez, A.;
Wester, R. T.; Allen, M. C.; Brown, J. A.; Buchholz, A. R.; Cook, E. R.;
Day, W. W.; Hamanaka, E. S.; Kennedy, S. P.; Knight, D. R. Bioorg.
Med. Chem. Lett. 2001, 11, 803. (c) Chimenti, F.; Fioravanti, R.;
Bolasco, A.; Manna, F.; Chimenti, P.; Secci, D.; Befani, O.; Turini, P.;
Ortuso, F.; Alcaro, S. J. Med. Chem. 2007, 50, 425. (d) Okuno, S.; Saito,
A.; Hayashi, T.; Chan, P. H. J. Neurosci. 2004, 24, 7879. (e) Wasylyk, C.;
Zheng, H.; Castell, C.; Debussche, L.; Multon, M.-C.; Wasylyk, B.
Cancer Res. 2008, 68, 1275. (f) Wu, C.-H.; Hung, M.-S.; Song, J.-S.; Yeh,
T.-K.; Chou, M.-C.; Chu, C.-M.; Jan, J.-J.; Hsieh, M.-T.; Tseng, S.-L.;
Chang, C.-P. J. Med. Chem. 2009, 52, 4496. (g) Ivachtchenko, A. V.;
Golovina, E. S.; Kadieva, M. G.; Kysil, V. M.; Mitkin, O. D.; Tkachenko,
S. E.; Okun, I. M. J. Med. Chem. 2011, 54, 8161. (h) Ivachtchenko, A. V.;
Dmitriev, D. E.; Golovina, E. S.; Kadieva, M. G.; Koryakova, A. G.;
Kysil, V. M.; Mitkin, O. D.; Okun, I. M.; Tkachenko, S. E.; Vorobiev,
A. A. J. Med. Chem. 2010, 53, 5186. (i) Ivachtchenko, A. V.; Golovina,
E. S.; Kadieva, M. G.; Kysil, V. M.; Mitkin, O. D.; Vorobiev, A. A.;
Okun, I. Bioorg. Med. Chem. Lett. 2012, 22, 4273.
Previous studies from our group have reported a concise
approach to prepared N-propargylic N-sulfonylhydra-
zones through FeCl3-catalyzed nucleophilic substitution
(3) For recent examples, see: (a) Ye, M.; Edmunds, A. J.; Morris,
J. A.; Sale, D.; Zhang, Y.; Yu, J.-Q. Chem. Sci. 2013, 4, 2374. (b)
Goikhman, R.; Jacques, T. L.; Sames, D. J. Am. Chem. Soc. 2009, 131,
ꢁ
3042. (c) Grosse, S.; Pillard, C.; Massip, S.; Leger, J. M.; Jarry, C.;
Bourg, S.; Bernard, P.; Guillaumet, G. Chem.;Eur. J. 2012, 18, 14943.
(d) Yan, T.; Chen, L.; Bruneau, C.; Dixneuf, P. H.; Doucet, H. J. Org.
Chem. 2012, 77, 7659. (e) Pan, X.; Luo, Y.; Wu, J. J. Org. Chem. 2013, 78,
5756. (f) Ma, W.; Graczyk, K.; Ackermann, L. Org. Lett. 2012, 14, 6318.
(g) Mateos, C.; Mendiola, J.; Carpintero, M.; Mınguez, J. M. Org. Lett.
€
2010, 12, 4924. (h) Enders, D.; Grossmann, A.; Gieraths, B.; Duzdemir,
M.; Merkens, C. Org. Lett. 2012, 14, 4254.
(4) For recent examples, see: (a) Neumann, J. J.; Suri, M.; Glorius, F.
Angew. Chem., Int. Ed. 2010, 49, 7790. (b) Kinjo, R.; Donnadieu, B.;
Bertrand, G. Angew. Chem., Int. Ed. 2011, 50, 5560. (c) Hao, L.; Hong,
J. J.; Zhu, J.; Zhan, Z. P. Chem.;Eur. J. 2013, 19, 5715. (d) Wang, L.;
Yu, X.; Feng, X.; Bao, M. J. Org. Chem. 2013, 78, 1693. (e) Attanasi,
O. A.; Favi, G.; Geronikaki, A.; Mantellini, F.; Moscatelli, G.; Paparisva,
A. Org. Lett. 2013, 15, 2624. (f)Wang, H.;Zhao, Y. L.;Li, L.;Zhang, Z. W.;
Liu, Q. Adv. Synth. Catal. 2013, 355, 1540. (g) Wang, L.; Huang, J.; Gong,
X.; Wang, J. Chem.;Eur. J. 2013, 19, 7555. (h) Li, X.; He, L.; Chen, H.;
Wu, W.; Jiang, H. J. Org. Chem. 2013, 78, 3636. (i) Dissanayake, A. A.;
Odom, A. L. Chem. Commun. 2012, 48, 440.
(2) For reviews on the synthesis of pyrazole, see: (a) Fustero, S.;
ꢀ
ꢀ
ꢀ
Sainchez-Roselloi, M.; Barrio, P.; Simoin-Fuentes, A. Chem. Rev. 2011,
111, 6984. (b) Janin, Y. L. Chem. Rev. 2012, 112, 3924. (c) Dadiboyena,
S.; Nefzi, A. Eur. J. Med. Chem. 2011, 46, 5258. (d) Svete, J. ARKIVOC
2006, 7, 35. (e) Anwar, H.; Elnagdi, M. ARKIVOC 2009, 1, 198. (f)
Makino, K.; Kim, H. S.; Kurasawa, Y. J. Heterocycl. Chem. 1998, 35,
489. (g) Makino, K.; Kim, H. S.; Kurasawa, Y. J. Heterocycl. Chem.
1999, 36, 321.
r
10.1021/ol401818m
XXXX American Chemical Society